P4–410: Steady–state pharmacokinetics of rivastigmine in patients with mild to moderate Alzheimer's disease are not affected by co–administration of memantine
العنوان: | P4–410: Steady–state pharmacokinetics of rivastigmine in patients with mild to moderate Alzheimer's disease are not affected by co–administration of memantine |
---|---|
المؤلفون: | Sandeep Athalye, Greg Sedek, Picard Frank, Françoise Pommier, Juanita Smith, Joshua R. Shua-Haim, Gilbert Lefèvre |
المصدر: | Alzheimer's & Dementia. 2 |
بيانات النشر: | Wiley, 2006. |
سنة النشر: | 2006 |
مصطلحات موضوعية: | Rivastigmine, biology, Epidemiology, business.industry, Health Policy, Memantine, Disease, Pharmacology, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Pharmacokinetics, medicine, biology.protein, In patient, Neurology (clinical), Steady state (chemistry), Geriatrics and Gerontology, business, medicine.drug, Co administration, Cholinesterase |
الوصف: | Background and objective: It has been shown that combining memantine and a cholinesterase inhibitor, which each affect different neurotransmitter systems, may offer further improvements in efficacy over either treatment alone in patients with Alzheimer’s disease. The present study was conducted to determine if memantine has any effects on the steady-state pharmacokinetics of rivastigmine in patients with mild to moderate Alzheimer’s disease. |
تدمد: | 1552-5279 1552-5260 |
URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::715b8eaf4ebd70d6955448eacb030b83 https://doi.org/10.1016/j.jalz.2006.05.2152 |
حقوق: | OPEN |
رقم الأكسشن: | edsair.doi...........715b8eaf4ebd70d6955448eacb030b83 |
قاعدة البيانات: | OpenAIRE |
تدمد: | 15525279 15525260 |
---|